Special notice
Notice of Intent to Award Sole Source - Extension of Mammography Quality Standards Act (MQSA) Certification and Hotline Inquiries Contract
FDA-NOI-133411
Food and Drug Administration, FDA Office of Acq Grant SVCS. Custom Computer Programming Services.
Response deadline
April 3, 2026 at 5:00 PM EDT
Closed 167 days ago. Posted March 30, 2026, first published March 30, 2026. Scheduled to archive April 4, 2026.
Description
As published on SAM.gov.
The Food and Drug Administration (FDA) intends to award a Sole Source labor hour 6-month contract extension to Impyrian LLC, 8115 Maple Lawn BLVD, Suite 260, Fulton, Maryland 20759-2681 for the Mammography Quality Standards Act Program, in accordance with the authority under FAR Part 6 (i.e. 6.103-1, Only One Responsible Source). This procurement is being extended through the acquisition procedures in accordance with FAR Part 52.217-8. The NAICS Code for this action is 541511 – Custom Computer Programming Services.
The primary objective of this requirement is to 1. operate and maintain the current system for the issuance of federal certificates to mammography facilities under the MQSA. 2. Operate and maintain the current MQSA hotline certification inquiries system, including real-time responses, maintaining records of written, telephone, email, and fax inquiries from facilities, consumers, MSQA inspectors and mammography stakeholders.
3. Operate and maintain the current database system to scan all mammography certification letters mailed to facilities. The scope of the activities supported by this contract requires the Contractor to perform in support of the Mammography Quality Standards Act (MQSA) Facility Certificate Issuance and Hotline Inquiries program functions.
DMQS provides technical and administrative information to mammography manufactures (post-marked), mammography facilities, consumers, MQSA inspectors, FDA-approved accreditation body stakeholders, FDA-approved certifying agencies and FDA CDRH program offices through responses to inquires via email messages, phone calls, faxes and written communications pertaining to the MQSA program related matters.
Responses: Responses to this notice should be sent to Thomas Lawson at Thomas.lawson@fda.hhs.gov NLT 5:00 pm (EDT), April 3, 2026. This notice is not a request for competitive quotes. Any other firms desiring consideration must fully identify their interest and capability of meeting the requirements by submitting a capability statement. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed requirement based upon a response to this notice is solely within the discretion of the Government.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Also open from this buyer
- Human Hindbrain Organoid Functional Assay Services.Combined synopsis and solicitationNAICS 541714RFQ_CDR-2026-135968Closes todaySep 17
- Walk-In Laboratory CoolerSolicitationNAICS 33341575F40126Q00386Closes tomorrowSep 18
- Rapid Nicotine Pouch Data Analysis ServicesCombined synopsis and solicitationNAICS 541618Silver Spring, MD75F40126Q00407Closes tomorrowSep 18
- Vanquish Neo System and Ion Chromatography systemSolicitationNAICS 33451675F40126Q000430Closes in 4 daysSep 21
- 2D High-Density Multi-Electrode Array Electrophysiology PlatformCombined synopsis and solicitationNAICS 334516RFQ_CBER-2026-135968Closes in 6 daysSep 23